hepatitis

(redirected from Chronic hepatitis)
Also found in: Thesaurus, Medical, Acronyms, Encyclopedia.
Related to Chronic hepatitis: Chronic Hepatitis B

hep·a·ti·tis

 (hĕp′ə-tī′tĭs)
n. pl. hep·a·tit·i·des (-tĭt′ĭ-dēz′)
1. Inflammation of the liver, caused by infectious or toxic agents and characterized by jaundice, fever, liver enlargement, and abdominal pain.
2. Any of various types of such inflammation, especially viral hepatitis.

hepatitis

(ˌhɛpəˈtaɪtɪs)
n
(Pathology) inflammation of the liver, characterized by fever, jaundice, and weakness. See hepatitis A, hepatitis B, hepatitis C

hep•a•ti•tis

(ˌhɛp əˈtaɪ tɪs)

n.
inflammation of the liver, caused by a virus or a toxin and characterized by jaundice, liver enlargement, and fever.
[1720–30; < Greek hēpatîtis. See hepato-, -itis]

hep·a·ti·tis

(hĕp′ə-tī′tĭs)
Inflammation of the liver, usually caused by infection with a virus. It is characterized by jaundice, fever, and weakness.

hepatitis

an inflamed condition of the liver.
See also: Disease and Illness
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.hepatitis - inflammation of the liver caused by a virus or a toxin
liver disease - a disease affecting the liver
infectious disease - a disease transmitted only by a specific kind of contact
viral hepatitis - hepatitis caused by a virus
delta hepatitis, hepatitis delta - a severe form of hepatitis
Translations
žloutenka
hepatitis
maksatulehdus
hepatitis
肝炎
간염
hepatit
โรคตับอักเสบ
bệnh viêm gan

hepatitis

[ˌhepəˈtaɪtɪs] Nhepatitis f

hepatitis

[ˌhɛpəˈtaɪtɪs] nhépatite f

hepatitis

nHepatitis f

hepatitis

[ˌhɛpəˈtaɪtɪs] nepatite f

hepatitis

إِلتِهَابُ الكَبِد žloutenka hepatitis Hepatitis ηπατίτιδα hepatitis maksatulehdus hépatite hepatitis epatite 肝炎 간염 hepatitis hepatitt zapalenie wątroby hepatite гепатит hepatit โรคตับอักเสบ karaciğer iltihabı bệnh viêm gan 肝炎

hep·a·ti·tis

n. hepatitis, infl. del hígado;
amebic ______ amébica;
active chronic ______ crónica activa;
cholestatic ______ colestática;
drug-induced ______ inducida por drogas;
epidemic ______ epidémica;
fulminating ______ fulminante;
fulminating chronic ______ fulminante crónica;
fulminant ______ aguda fulminante;
___ A___ A, viral, afecta primordialmente a los niños;
___ B___ B, causada por un virus y trasmitida en líquidos del organismo; saliva, lágrimas, semen;
infectious ______ infecciosa o viral;
non-A, non-B ______ no A, no B, asociada con transfusiones de sangre;
serum ______ sérica;
persistent chronic ______ persistente crónica.

hepatitis

n hepatitis f; — A (B, C, etc.) hepatitis A (B, C, etc.)
References in periodicals archive ?
German biotechnology company MYR Pharma GmbH said on Thursday that it has completed the 48-week-long active treatment phase under its MYR 203 clinical trial of Myrcludex B for the treatment of chronic hepatitis Delta (HDV) infection.
We will continue to study ZEPATIER to understand even more about its role in treating chronic hepatitis C infection and will continue to work with others to help bring ZEPATIER to appropriate patients with chronic hepatitis C genotype 1 or 4 infection, the genotypes which make up the majority of patients with chronic hepatitis C infection.
Globally, an estimated 71 million people have chronic hepatitis C infection.
Key Words: Chronic hepatitis B, HBeAg, Seroprevalance
Although there is no cure, chronic hepatitis B can be a manageable disease.
An observational cohort study of 10,131 patients with chronic hepatitis C virus (HCV) infection (the Chronic Hepatitis Cohort Study) and 20,262 health system patients showed the overall hospitalization rate was 3.
Methods: A total of 67 patients diagnosed with chronic hepatitis B and 77 patients diagnosed with chronic hepatitis C infection based on HBs Ag Anti HCV HBe Ag Anti HBe Ag HBV DNA HCV RNA liver ultrasound and liver biopsy results as well as 48 healthy individuals were included in this study.
Elevated plasma levels of N-terminal pro-brain natriuretic peptide in patients with chronic hepatitis C during interferon-based antiviral therapy.
The treatment of chronic hepatitis B aims to prevent or reduce the development of liver cirrhosis and hepatocellular carcinoma, and also aims to suppress viral replication, normalize ALT levels, decrease liver damage, and obtain HBsAg seroconversion.
Individuals with chronic hepatitis B (CHB) have increased risk of developing liver cirrhosis and hepatocellular carcinoma (HCC).
52%) patients treated within clinical trials, were recorded to have lymphadenopathy during combination antiviral therapy for chronic hepatitis C.
The story begins in 1968 when an International Working Group of hepatopathologists, known as "the Gnomes," published the first classification of chronic hepatitis based on histologic criteria, with the hope of predicting which patients were at greater risk of disease progression.

Full browser ?